好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Effect of Fibrinogen Levels on Three-month Neurological Recovery in Acute Ischemic Stroke Patients
Cerebrovascular Disease and Interventional Neurology
P10 - Poster Session 10 (8:00 AM-9:00 AM)
5-005
To investigate the relationship between post-stroke fibrinogen levels and three-month prognosis in patients experiencing their first ischemic stroke, and to determine the impact of fibrinogen on morbidity and mortality.
Fibrinogen, a key coagulation factor and acute-phase reactant, has been implicated in the pathophysiology and outcomes of ischemic stroke. Elevated levels may reflect a pro-thrombotic and pro-inflammatory state that could influence neurological recovery.
This prospective study included 100 consecutive patients admitted with a first ischemic stroke to the Neurology Clinic of Gaziantep City Hospital. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS) and functional outcome with the modified Rankin Scale (mRS) at baseline and at 3-month follow-up. Serum fibrinogen levels obtained from routine blood tests during the acute phase were recorded. Correlations between fibrinogen levels and clinical outcomes were analyzed using Pearson correlation and linear regression.
Fibrinogen levels showed significant positive correlations with stroke severity and functional outcome both at admission and at 3 months. Baseline fibrinogen was associated with NIHSS (r = 0.371, p < 0.001) and mRS (r = 0.439, p < 0.001) scores. At three months, fibrinogen remained significantly related to NIHSS (r = 0.544, p < 0.001) and mRS (r = 0.538, p < 0.001). Regression analysis indicated that each one-unit increase in fibrinogen predicted a 0.018-unit rise in NIHSS and a 0.008-unit rise in mRS scores (p < 0.001).

Elevated fibrinogen levels during the acute phase of first-ever ischemic stroke are independently associated with worse neurological outcomes and higher morbidity and mortality at three months. Fibrinogen may serve as a prognostic biomarker to guide early management and rehabilitation strategies in ischemic stroke patients.
Authors/Disclosures
Buket Yılmaz, MD
PRESENTER 		Dr. Yilmaz has nothing to disclose.
Ramazan Sencan, MD Dr. Sencan has nothing to disclose.